Active Ingredient History
Magnesium ascorbate is a non-acidic buffered form of Vitamin C and a source of the essential mineral Magnesium. The in vitro model system consisted of the isolated section of rat small intestine. The sources of magnesium ion (Mg2+) were magnesium chloride, magnesium sulphate, magnesium acetate, magnesium lactate, magnesium hydrocitrate and magnesium ascorbate. Magnesium ions from magnesium ascorbate were absorbed after the first 15 minutes to the highest extent of all salts, but after 120 minutes their absorption was the smallest of all. The use of magnesium ascorbate in food supplements may lead to an additional exposure to vitamin C and Magnesium. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Ablation Techniques (Phase 2)
Achlorhydria (Phase 1)
Acidosis, Lactic (Phase 2/Phase 3)
Acne Vulgaris (Phase 1/Phase 2)
Acute Kidney Injury (Phase 4)
Acute Lung Injury (Phase 2)
Adenocarcinoma (Phase 2)
Aging (Phase 4)
Albuminuria (Phase 2)
Alcohol Withdrawal Delirium (Phase 2/Phase 3)
Alveolar Bone Loss (Phase 2)
Alzheimer Disease (Phase 1)
Anemia ()
Anemia, Iron-Deficiency (Phase 4)
Angina Pectoris (Phase 4)
Anti-Infective Agents, Local (Phase 2)
Antioxidants (Phase 4)
Appetite (Phase 3)
Arterial Occlusive Diseases (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Ascorbic Acid (Phase 3)
Ascorbic Acid Deficiency (Phase 2)
Aspirin (Phase 4)
Asthma (Phase 2)
Astrocytoma (Phase 1)
Atherosclerosis (Phase 2)
Atrial Fibrillation (Phase 3)
Atrial Flutter (Phase 3)
Attention Deficit Disorder with Hyperactivity (Phase 2/Phase 3)
Autistic Disorder (Phase 1)
Avitaminosis (Phase 2)
beta-Thalassemia (Phase 2/Phase 3)
Biomarkers (Phase 2)
Blood Pressure (Early Phase 1)
Body Fluids (Phase 4)
Brain Injuries (Phase 2)
BRCA1 Protein (Phase 2)
Breast Neoplasms (Phase 1/Phase 2)
Burns (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Basal Cell (Early Phase 1)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cardiovascular Diseases (Phase 4)
Carotid Artery Diseases (Phase 2)
Cataract (Phase 3)
Catheter-Related Infections (Early Phase 1)
Central Serous Chorioretinopathy (Phase 2)
Cerebrovascular Disorders (Phase 2)
Charcot-Marie-Tooth Disease (Phase 2/Phase 3)
Cholecystitis (Phase 4)
Clonal Hematopoiesis (Phase 2)
Cognition (Phase 4)
Colitis, Ulcerative (Phase 4)
Colon (Phase 4)
Colonic Diseases (Phase 4)
Colonic Neoplasms (Phase 1/Phase 2)
Colonic Polyps (Phase 3)
Colonoscopy (Phase 4)
Colorectal Neoplasms (Phase 4)
Common Cold (Phase 4)
Constipation (Phase 2)
Coronary Artery Bypass (Phase 1)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 3)
Coronavirus (Phase 3)
Coronavirus Infections (Phase 4)
COVID-19 (Phase 4)
C-Reactive Protein (Phase 3)
Critical Illness (Phase 4)
Cystic Fibrosis (Phase 2)
Deficiency Diseases (Phase 2/Phase 3)
Depression (Phase 2)
Dermatology (Phase 1)
Desmoplastic Small Round Cell Tumor (Phase 2)
Diabetes, Gestational (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Foot (Phase 4)
Diabetic Neuropathies (Phase 1)
Diabetic Retinopathy (Phase 3)
Diarrhea (Phase 2)
Eclampsia (Phase 3)
Endometriosis (Phase 2)
Endothelial Cells (Phase 1)
Endothelium (Phase 4)
Epilepsy (Phase 2)
Exercise Tolerance (Phase 2/Phase 3)
Fatigue (Phase 2/Phase 3)
Fatigue Syndrome, Chronic (Phase 4)
Fatty Liver (Phase 1)
Fibrosis (Phase 2/Phase 3)
Fragile X Syndrome (Phase 3)
Frailty (Phase 2)
Gastroenteritis (Phase 3)
General Surgery (Phase 1)
Gingival Diseases (Phase 4)
Glioblastoma (Phase 2)
Glioma (Phase 3)
Gliosarcoma (Phase 1)
Glycemic Control (Phase 2)
Graves Ophthalmopathy (Phase 2/Phase 3)
Growth and Development (Phase 1)
Growth Hormone (Phase 2)
Healthy Volunteers (Phase 4)
Hearing Loss, Noise-Induced (Phase 2)
Heart Arrest (Phase 2)
Heart Disease Risk Factors (Phase 1)
Heart Diseases (Phase 3)
Heart Failure (Phase 1)
Heart Valve Diseases (Phase 1)
Helicobacter pylori (Phase 4)
HELLP Syndrome (Phase 3)
Hemodialysis, Home (Phase 2)
Hepatitis, Alcoholic (Phase 4)
Hepatitis C, Chronic (Phase 4)
Hepatitis, Chronic (Phase 4)
Hereditary Sensory and Motor Neuropathy (Phase 2)
HIV (Phase 2)
Hodgkin Disease (Phase 2)
Hospitalization (Phase 3)
Hypertension (Phase 1/Phase 2)
Hypertension, Pulmonary (Phase 1)
Hypotension (Phase 1/Phase 2)
Hypoxia (Phase 1/Phase 2)
Hysterectomy (Phase 3)
Immune System (Phase 2)
Immunologic Factors (Phase 2)
Infant, Premature (Phase 3)
Infertility, Male (Phase 4)
Inflammation (Phase 4)
Influenza A Virus, H1N1 Subtype (Phase 4)
Influenza, Human (Phase 4)
Insulin Resistance (Phase 2/Phase 3)
Intensive Care Units (Phase 3)
Intermittent Claudication (Phase 1)
Intestine, Large (Phase 4)
Intracranial Arteriosclerosis (Phase 2)
Iron Deficiencies (Phase 3)
Iron Overload (Phase 4)
Kidney Calculi (Phase 4)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 3)
Laparoscopy (Phase 4)
Lead Poisoning (Phase 2/Phase 3)
Leiomyoma (Phase 3)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Monocytic, Acute (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Live Birth (Phase 4)
Liver Neoplasms (Phase 2)
Liver Transplantation (Phase 4)
Lung Diseases (Phase 2/Phase 3)
Lung Neoplasms (Phase 2)
Lung Transplantation (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Macular Degeneration (Phase 3)
Magnesium Deficiency (Phase 2/Phase 3)
Magnesium Sulfate (Phase 2)
Malnutrition (Phase 3)
Metabolic Diseases (Phase 3)
Metabolic Syndrome (Phase 4)
Migraine Disorders (Phase 3)
Multiple Myeloma (Phase 2)
Multiple Organ Failure (Phase 4)
Mutation (Phase 2)
Mycobacterium tuberculosis (Phase 3)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Myocardial Infarction (Phase 2)
Myocardial Ischemia (Phase 3)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2/Phase 3)
Nicotine (Phase 2/Phase 3)
Obesity (Phase 4)
Oligodendroglioma (Phase 1)
Osteosarcoma (Phase 2)
Out-of-Hospital Cardiac Arrest (Phase 2)
Ovarian Neoplasms (Phase 2)
Oxalates (Phase 4)
Oxidative Stress (Phase 3)
Pain (Phase 3)
Pain, Postoperative (Phase 4)
Palliative Care (Phase 2)
Pancreatic Neoplasms (Phase 4)
Pancreatitis (Phase 2/Phase 3)
Pandemics (Phase 3)
Periodontitis (Phase 2)
Peripheral Arterial Disease (Phase 1)
Peripheral Vascular Diseases (Phase 1)
Peritoneal Dialysis (Phase 3)
Pharmacokinetics (Phase 1)
Pneumonia (Phase 2)
Pneumonia, Ventilator-Associated (Phase 2)
Pneumonia, Viral (Phase 2)
Polycythemia Vera (Phase 1)
Post-Cardiac Arrest Syndrome (Phase 2)
Postmenopause (Phase 3)
Postoperative Complications (Early Phase 1)
Postpartum Hemorrhage (Early Phase 1)
Postural Orthostatic Tachycardia Syndrome (Early Phase 1)
Pre-Eclampsia (Phase 3)
Pregnancy (Phase 3)
Pregnancy Complications (Phase 4)
Prehypertension (Phase 2)
Primary Graft Dysfunction (Phase 2)
Primary Myelofibrosis (Phase 1)
Prostatic Neoplasms (Phase 2)
Prostheses and Implants (Phase 2)
Psychological Distress (Phase 1)
Psychotic Disorders (Phase 2/Phase 3)
Pulmonary Alveolar Proteinosis (Phase 1/Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 2/Phase 3)
Rectal Neoplasms (Phase 2)
Reflex Sympathetic Dystrophy (Phase 4)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Reperfusion Injury (Phase 4)
Respiratory Distress Syndrome (Phase 3)
Respiratory Insufficiency (Phase 2)
Respiratory Tract Infections (Phase 3)
Restless Legs Syndrome (Phase 2/Phase 3)
Safety (Phase 1)
Sarcoma (Phase 2)
SARS-CoV-2 (Phase 4)
Schizophrenia (Phase 4)
Semen Analysis (Phase 4)
Sepsis (Phase 4)
Severe Acute Respiratory Syndrome (Phase 3)
Shock (Phase 2)
Shock, Septic (Phase 4)
Shoulder Injuries (Phase 4)
Signs and Symptoms, Respiratory (Phase 2/Phase 3)
Sleep Apnea Syndromes (Early Phase 1)
Smoking (Phase 2)
Spinal Cord Injuries (Phase 4)
Spinal Diseases (Early Phase 1)
Sprains and Strains (Phase 2)
Stem Cell Transplantation (Phase 1/Phase 2)
Stomach Neoplasms (Phase 3)
Stomatitis (Phase 2/Phase 3)
Stress, Psychological (Phase 4)
Stroke (Phase 1)
Subarachnoid Hemorrhage (Phase 3)
Systemic Inflammatory Response Syndrome (Phase 4)
Temporomandibular Joint Disorders (Phase 1/Phase 2)
Thoracic Surgery (Phase 4)
Thrombocythemia, Essential (Phase 1)
Tobacco Smoke Pollution (Phase 2/Phase 3)
Transfusion-Related Acute Lung Injury (Phase 2)
Tuberculosis (Phase 2)
Uremia (Phase 4)
Urinary Bladder Neoplasms (Phase 1/Phase 2)
Urinary Tract Infections (Phase 4)
Urological Manifestations (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Uterine Neoplasms (Phase 2)
Vascular Diseases (Phase 3)
Vascular Stiffness (Early Phase 1)
Vasoconstriction (Phase 1)
Vasodilation (Early Phase 1)
Vasoplegia (Phase 2)
Vitamin D Deficiency (Phase 2)
Weight Loss (Phase 4)
Wernicke Encephalopathy (Phase 2/Phase 3)
Wounds and Injuries (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
